PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'School of Life Sciences, Arizona State University, Tempe AZ, USA. Electronic address: douglas.lake@asu.edu.\', \'School of Life Sciences, Arizona State University, Tempe AZ, USA.\', \'Mayo Clinic Arizona, Department of Laboratory Medicine and Pathology, Scottsdale, AZ, USA.\', \'College of Health Solutions, Arizona State University, Phoenix AZ, USA.\', \'Department of Pathology, University of Texas Medical Branch at Galveston, Galveston, TX USA; Galveston National Laboratory, University of Texas Medical Branch at Galveston, Galveston, TX USA.\', \'Department of Pathology, University of Texas Medical Branch at Galveston, Galveston, TX USA; Galveston National Laboratory, University of Texas Medical Branch at Galveston, Galveston, TX USA; Department of Microbiology and Immunology University of Texas Medical Branch at Galveston, Galveston, TX USA.\', \'Mayo Clinic Rochester, Department of Laboratory Medicine and Pathology, Rochester, MN USA.\', \'Axim Biotechnologies Inc, San Diego, CA USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1386-6532(21)00291-210.1016/j.jcv.2021.105024
?:doi
?:hasPublicationType
?:journal
  • Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
is ?:pmid of
?:pmid
?:pmid
  • 34781240
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Development of a rapid point-of-care test that measures neutralizing antibodies to SARS-CoV-2.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all